台灣老年衰弱症研究 與防制策略 - tnst.org.t · 台灣老年衰弱症研究...
TRANSCRIPT
台灣老年衰弱症研究台灣老年衰弱症研究與防制策略與防制策略陳慶餘台大醫學院家庭醫學科台灣老年學暨老年醫學會
1
2010/12/162010/12/16 台日高齡化社會研討會台日高齡化社會研討會
Senility: MultiSenility: Multi--systems declinesystems decline
2
Psycho-Neuro-Musculoskeletal systemsIncluding Vision, Hearing,
Communication
GastrointestinalEndocrine
Metabolismsystems
Skin system
CardiopulmonaryHemato immune
systems
Genito-Urinary systems
衰老:多重器官系統
功能衰退
3
Goal: Early detection and disability Goal: Early detection and disability preventionprevention
(Multi-systems)
早期偵測和失能預防
Normal ageing
Frailty Syndrome
Performance
Pre-Frail
Frailty
Age
Disability
Percentage of people reporting chronic diseases, Percentage of people reporting chronic diseases, by age and number of diseases, Taiwan, 2001by age and number of diseases, Taiwan, 2001
Percent
Source: 2001 NHIS, Taiwan
Chronic diseases indicate stroke, DM, hypertension, and disease of heart, lung, liver, and kidney.
共病症情況
5
Geriatric Syndrome –an overlapping concept
AGING-Increased vulnerability to
disease and accidents over time
Geriatric Syndrome
Multidimensional
Unstable
Heterogeneous
DISABILITY-Functional limitations
resulting from impairments
COMORBIDITY-Disease processes
resulting from biology
and exposures
老病失能之關念
Six Concepts of Geriatric SyndromeSix Concepts of Geriatric Syndrome老年病症候群老年病症候群
Aging-related: time factor, life span, how old?
Multi-system involved: psycho-neuro-communication- musculoskeletal axis
Function declining: mobility-centered
Complex etiology: bio-psycho-socio-environmental and spiritual factors, beyond evolution
Poor outcome: vulnerable, disability, medical overuse, mortality
Treatable: the earlier the better
6
Common geriatric syndromeCommon geriatric syndrome常見老年病症候群常見老年病症候群
Functional decline, Frailty Fatigue, anorexia, weight loss and
malnutrition 3D’s (dementia, delirium, depression) Sleep disorder, Dizziness Immobility, falls and gait disorder,
Pressure sore Incontinence/chronic constipation Polypharmacy Pain
7
Published(255)台灣老年醫學研究 (1989-2008) n %A. Gerontology 74 29.0
1.Biomarker 4 1.6
2.Elder Communication/ Social Activity/ Emotional Reaction 34 13.3
3.Longevity/ Mortality 5 2.04.Quality of Life 26 10.25.Gender Issue 5 2.0
B. Geriatric Syndrome 142 55.71.Frailty / Mobility/ Disability/ Fall 54 21.22.Cognitive/Depression/Dementia/Delirium 49 19.2
3.Nutrition/ Metabolic Syndrome/ Obesity (Body Composition) 17 6.7
4.Other Geriatric Syndrome (Incontinence, vision, sleep, pain, dysphagia, others)
22 8.6
C. Geriatric Care 35 13.41.Disease Prevention 1 0.42.CGA 5 2.03.Home care/ Long-term Care 17 6.74.Palliative Care 1 0.45.Physical Exercise/ Rehabilitation 11 4.3
D. Geriatric Policy and Education 4 1.61.Health Promotion/Integrated care model 4 1.62.Geriatric Education Training 0 0.0 8
Growth in the Number of Papers on Geriatric Growth in the Number of Papers on Geriatric Studies in Taiwan Studies in Taiwan 老年醫學論文數老年醫學論文數
9
Breakdown of Papers on Geriatric Syndrome Studies in Breakdown of Papers on Geriatric Syndrome Studies in Taiwan by AuthorTaiwan by Author’’s Academic/ Professional Background s Academic/ Professional Background
老年醫學研究領域老年醫學研究領域
10
老化與疾病造成的功能衰退及不良預後之研究架構老化與疾病造成的功能衰退及不良預後之研究架構
11
老化
疾病
功能衰退
•自由基•老化細胞•遠端粒縮短
•DNA損害•系統損害/負荷•發炎
•神經退化•癌症•慢性感染
•心血管疾病•糖尿病/肥胖
發炎
代謝改變
神經內分泌失調
獨特性老年病症候群
•瞻妄•憂鬱•貧血•吞嚥困難•便秘•尿失禁•壓瘡•失眠
表現性老年病症候群
•衰弱•體重減輕•耗竭•肌力弱•活動少
共同危險因子
•年齡•認知功能•營養•身體活動•自我照顧能力
不良預後
•跌倒•失能•依賴•死亡
原因 機轉 器官系統功能
身體功能
結果
圖示老年病症候群與衰弱症研究進展圖示老年病症候群與衰弱症研究進展
12
衰弱症相關因子及預後研究
新穎生物指標研究
老年病症候群相關研究
老年周全性評估(兩階段)
老化
疾病
功能衰退
•自由基•老化細胞•遠端粒縮短
•DNA損害•系統損害/負荷•發炎
•神經退化•癌症•慢性感染
•心血管疾病•糖尿病/肥胖
發炎
代謝改變
神經內分泌失調
獨特性老年病症候群
•瞻妄•憂鬱•貧血•吞嚥困難•便秘•尿失禁•壓瘡•失眠
表現性老年病症候群
•衰弱•體重減輕•耗竭•肌力弱•活動少
共同危險因子
•年齡•認知功能•營養•身體活動•自我照顧能力
不良預後
跌倒 失能 依賴 死亡
原因 機轉 器官系統功能 身體功能 結果
Frailty Assessment by Revised CriteriaFrailty Assessment by Revised Criteria衰弱症評估指標衰弱症評估指標
13
Dr. Fried Criteria Weight loss > 3 kg/yr
Exhaustion: as defined either one question positive◦ (a) I felt that everything I did was an
effort; (b) I could not get going. Low physical activity:
◦ men < 383 Kcal/wk; ◦ women < 270 Kcal/wk
Walk time:◦ men: height <=173 cm, >= 7 sec;
>173 cm, >=6 sec◦ women: height <=159 cm, >= 7 sec;
>159 cm, >=6 sec Grip strength: stratified by gender
and BMI◦ Men: <=29-32◦ Women: <=17-21
Revised Frailty Criteria (Taiwan) Weight loss > 3 kg/yr
Exhaustion: as defined either one question positive
Low physical activity:◦ men < 642 Kcal/wk; ◦ women < 396 Kcal/wk
Walk time:◦ men: >= 7 sec, ◦ women: >= 7sec
Grip strength:◦ men: <=23 kg; ◦ women: <= 14 kg
Frailty Study
Prevalence of FrailtyPrevalence of Frailty社區衰弱症盛行率社區衰弱症盛行率
14
Indicators§ N %
Shrinking 52 18.9
Exhaustion 47 17.1
Low physical activity 19 6.9
Slowness 43 15.6
Weakness 129 46.9
Frailty status§(N=275)
Robust 81 29.5
Pre-frail 161 58.5
Frail 31 11.3
Frailty status★§
Robust 228 53.6
Pre-frail 161 37.9
Frail 34 8.0
★N = 425 including subjects with scored 1, 2, 7 of the
CCSHA_CFS_TV
§ There are two cases with missing data
Frailty StudyCommunity
15
Factors Associated with Frailty by Factors Associated with Frailty by Multinomial Logistic RegressionMultinomial Logistic Regression
Fried Frailty Index
Pre-frail vs Robust Frail vs Robust
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Age(Years)
65-68 1 1
69-79 2.77(1.54 ~ 5.01) 0.001 7.66(2.22 ~ 26.38) 0.001
Education(Years)
≧ 7 1 1
< 7 1.13(0.57 ~ 2.26) 0.724 13.40(1.55 ~ 116.24) 0.019
0 1.71(0.81 ~ 3.60) 0.157 10.60(1.18 ~ 95.07) 0.035
Barthel Index score 0.93(0.85 ~ 1.03) 0.159 0.87(0.78 ~ 0.97) 0.013
Depression by PHQ9 3.64(1.31 ~ 10.11) 0.013 10.04(2.85 ~ 35.39) < 0.001
95% CI = 95% confidence interval.
age 65-68 as reference group; education equal or more than 7 years as reference group
‧
Frailty StudyCommunity
影響因子影響因子
臨床兩階段周全性老年醫學評估臨床兩階段周全性老年醫學評估
16
主訴、現在史、過去史:疫苗、健康行為、手術、住院
目前用藥檢視 社會史:婚姻狀況、家庭情形、照顧者..
系統功能回顧:如跌倒、失禁
情緒狀況 營養評估 理學檢查、身高體重
一般功能評估: ◦ COOP/WONCA Chart;
◦ 簡式症狀量表(BSRS-5); ◦ WHO Quality of Life
日常生活功能評估 特殊功能評估:
◦ 老年虛弱評估◦ 器官系統功能評估 (MMSE.
GDS. MNA. ADL. IADL. DEEPIN)
實驗室檢驗、重要檢查報告 預立醫囑 評估與建議
年齡:80歲以上功能障礙老年症候群:如跌倒、失智、憂鬱、衰弱、失禁、功能下降…預計或已有高度醫療利用
篩檢
評估
CGA
Inclusion criteria: frail Inclusion criteria: frail vsvs nonnon--/pre/pre--frailfrail
17
Inclusion criteria Alln=189n(%)
Non & prefrailn=153n(%)
Frail n=36 n(%)
p
Age≧80 70 (37.0) 52 (34.0) 18 (50.0) .073Disease
number≧5110 (58.2) 83 (54.2) 27 (75.0) .023
Polypharmacy≧8 29 (15.3) 19 (12.4) 10 (27.8) .021
Mobility impairment
19 (10.1) 9 (5.9) 10 (27.8) <.001
Functional decline 57 (30.2) 51 (33.3) 6 (16.7) .050Fall in recent 1
year52 (27.5) 38 (24.8) 14 (38.9) .089
收案條件
Frailty StudyOPD
Functional Interview: frail Functional Interview: frail vsvs nonnon--/pre/pre--frail frail
18
Function review自報功能障礙
Alln=189 n (%)
Non & prefrailn=153
n(%)
Frail n=36
n(%)p
Imbalance 105 (55.6) 75 (49.0) 30 (83.3) <.001
Fall in recent 1 year 74 (39.2) 51 (32.7) 23 (63.9) .001
Depressive symptoms 55 (29.1) 33 (21.5) 22 (61.1) <.001
Memory impairment 147 (77.7) 112 (73.2) 35 (97.2) .002
Pain 140 (74.0) 108 (70.6) 32 (88.9) .024
Constipation 57 (30.2) 34 (22.2) 23 (63.9) <.001
Stool incontinence 22 (11.6) 9 (5.9) 13 (36.1) <.001
Urine incontinence 81 (42.9) 60 (39.2) 21 (58.3) .037
Swallowingdisturbance
29 (15.3) 18 (11.8) 11 (30.6) .005
Insomnia 77 (41.0) 60 (39.2) 18 (50.0) .237
Polypharmacy 152 (80.4) 121 (79.0) 31 (86.1) .339
Frailty StudyOPD
19
Active problem 活動性疾病
All n=189 n(%)
Non & prefrailn=153n(%)
Frailn=36
n(%)p
Common chronic diseases
Cataract 122 (64.5) 92 (60.1) 30 (83.3) .009
Hypertension 159 (84.1) 131 (85.6) 28 (77.8) .247
Osteoarthritis 90 (47.6) 70 (45.7) 20 (55.5) .289
Diabetes Mellitus 79 (41.7) 60 (39.2) 19 (52.7) .138
Cerebrovascular accident 51 (27.0) 36 (23.5) 15 (41.6) .027
Hyperlipidemia 115 (60.8) 101 (66.0) 14 (38.9) .003
OsteoporosisParkinsonism
34 (18.0) 10 (5.3)
20 (13.1)3 (2.0)
14 (38.9)7 (19.4)
<.001<.001
Depression* 17 (9.0) 12 (7.8) 5 (13.9) .254
Anemia*Congestive heart failure DementiaCOPD
13 (6.9)7 (3.7)7 (3.7)
16 (8.5)
8 (5.2)4 (2.6)4 (2.6)
14 (9.2)
5 (13.9)3 (8.3)3 (8.3)2 (5.6)
.065
.102
.102
.486
Common chronic diseases: frail Common chronic diseases: frail vsvs nonnon--/pre/pre--frailfrail
*Examples for further analysis
Frailty StudyOPD
20
Associated factors of frailty with logistic regression analysisAssociated factors of frailty with logistic regression analysis
Nonfrail-Frail* Pattern 1 Pattern 2 Pattern 3 Pattern 4 Pattern 5
Risk factors OR(95%CI) OR(95%CI) OR(95%CI) OR(95%CI) OR(95%CI)
Age 1.07(1.00,1.3)
Mobility impairment 8.97(3.09,26.03)
14.03 (3.75,52.56)
Fall 2.46(1.07, 5.68)
3.15(1.07, 9.22)
Disease number≧5 3.99 (1.26,12.60)
Polypharmacy≧8 3.97(1.55,10.21)
4.19 (1.13,15.54)
Hyperlipidemia 0.34(0.16, 0.74)
0.23(0.06, 0.68)
Cerebrovascularaccident
2.55(1.13, 5.72)
Cataract 3.61(1.36, 9.58)
Constipation 6.19(2.84,13.50)
5.32 (1.99,14.38)
Pattern 1: Only using baseline demographic data to predict frailty; Pattern 2: Only using inclusion criteria data to predict frailty; Pattern 3: Only using chronic diseases condition data to predict frailty; Pattern 4: Only using self-reported functional review data to predict frailty; Pattern 5: Using baseline demographic data、inclusion criteria data、chronic diseases condition data and self-reported functional review data to predict frailty.
衰弱症相關因子衰弱症相關因子Frailty Study
OPD
21
Example I Depressive mood with functional status 憂鬱情緒與身體功能
Frailty StudyOPD
22
Example I Depressive mood with frailty by Fried criteria 憂鬱情緒與衰弱症指標
Frailty StudyOPD
23
Example II Example II -- Functional indexes and Presence of Functional indexes and Presence of Anemia Status Anemia Status 貧血與貧血與衰弱症衰弱症
Anemia was defined using World Health Organization criteria as a hemoglobin level <13 g/dL for men or <12 g/dL for women.
Frailty StudyOPD
24
The crossThe cross--sectional areas of the muscle on both thighs sectional areas of the muscle on both thighs were calculated by tracing around the image. were calculated by tracing around the image. Measurement by software was performed on both legs Measurement by software was performed on both legs simultaneously.simultaneously.大腿核磁共振攝影
MRI StudyOPD
25
PearsonPearson’’s Correlations of MRIs Correlations of MRI--measured thigh muscle volumes with measured thigh muscle volumes with anthropometric measurements , BIA and physical function (N=69)anthropometric measurements , BIA and physical function (N=69)
Characteristic Correlation P value Age (yr) -.250 .039* Anthropometric measurement
Body height (cm) .645 .000* Body weight (kg) .772 .000*
Body mass index (kg/m2) .453 .000* Waist size (cm) .384 .001*
Thigh circumference (cm) .480 .000* Physical function
Physical activity (kcal) .037 .760 Grip strength (kg) -.077 .532
Quadriceps muscle power (kg) .467 .000* Up and go (sec) -.337 .005* Walk time (sec) -.347 .003*
Bioelectrical impedance analysis Fat mass (kg) .150 .221
Free-fat mass (kg) .775 .000* Predictive muscle size (kg) .773 .000*
*P<0.05, indicating a significant variable in the two-tail Pearson correlation test. † categorical data (gender and Chair rise) were not analyzed.
體位測量
身體功能体
生物電阻分析:體脂儀
MRI StudyOPD
26
Thigh muscle volume prediction formulaThigh muscle volume prediction formula
換算公式Thigh Muscle volume (cm3, by MRI) = 4226.3-42.5 × Age (year)-955.7 × gender (male=1,female=2)+ 45.9 × body weight (kg) + 60.0 × thigh circumference (cm)
r2 = 0.745, P < 0.001Standard Error of the Estimate = 581.6cm3
MRI StudyOPD
27
PearsonPearson’’s Correlations of predicted thigh muscle s Correlations of predicted thigh muscle volumes with BIA and physical function (N=189)volumes with BIA and physical function (N=189)
Characteristic Correlation P value Physical function
Quadriceps muscle power (kg) .481 <.001* Up and go (sec) -.113 .128
5m Walk time (sec) -.136 .066
Bioelectrical impedance analysis Predictive muscle mass (kg) .889 <.001*
* P<0.05, indicating a significant variable in the two-tail Pearson correlation test.
預測大腿肌肉量與身體功能和體脂儀之結果一致。
MRI StudyOPD
28
Thigh muscle volume, strength and gait speed in Thigh muscle volume, strength and gait speed in three Frail Groups by Fried criteria (N=189)three Frail Groups by Fried criteria (N=189)
Fried Robust(n = 46)
Pre-frail(n = 106)
Frail(n = 37)
pPost-hoc
Female 24 (52.2%) 52 (49.1%) 22 (59.5%) .551
Age 74.9 ± 6.6 77.6 ± 6.1 79.0 ± 4.8 .006 R<PF,F
Estimated Muscle Volume (cm3)
5048.4 ± 969.1 4984.6 ± 1044.7 4619.8 ± 758.2 .097
Muscle Index 27.05 ±4.98 24.05 ±5.79 24.83 ±5.83 .011 R>PF
Appendicular Muscle Mass (kg) 17.0 ±4.0 17.0 ±4.1 15.2 ±2.7 .049
Thigh Muscle Strengtha (nt) 139.5 ± 24.6 122.9 ± 31.1 118.1 ± 25.5 .001 R>PF,F
Up-Go Test (sec) 8.8 ± 2.4 13.0 ± 8.0 21.5 ± 13.9 .000 R<PF<F
5m Walk (sec) 4.04 ± 0.93 6.47 ± 3.88 11.42 ± 10.55 .000 R<PF<F
Muscle Index = 1000* (muscle strength/muscle volume) 預測大腿肌肉量與衰弱程度之檢定
MRI StudySarcopenia
29
11--yr follow up Frailty prediction yr follow up Frailty prediction
Predicting Variables
Dependent Age Muscle Index Up and Go Model Variables beta p beta p beta p R2
Frailty Score .220 .004 -.222 .003 .370 .000 .243
WONCA-COOP -- -- -.181 .019 .338 .000 .137
WHOQOL
Physical -- -- -- -- -.236 .004 .049
Psychological -- -- -- -- -.190 .021 .030
Note: -- variable did not enter in the model
預測大腿肌肉量預測一年後衰弱指數
MRI StudySarcopenia
30
Association of different biomarkers with FrailtyAssociation of different biomarkers with Frailty
Fulop T et al: aging frailty and age-related diseases. Biogerontology 2010
生物指標
Biomarker
31
Comparison of various cytokines with frail statusComparison of various cytokines with frail status細胞激素
Biomarker
32
Characteristics of study participants with insufficient vitamin D status 維生素D 缺乏Characteristics(categorical) Total 25(OH)D<20 (N=66) 25(OH)≧20 (N=147) p-value Gender(female) 126(59.2) 49(74.2) 77(52.4) 0.003
Fried Frailty Indicators robust 73(34.3) 12(18.2) 61(41.5) < 0.001 prefrail 119(55.9) 41(62.1) 78(53.1) frail 21(9.9) 13(19.7) 8(5.4) Timed Up and Go(sec) 0.001 0-10 129(60.6) 30(45.5) 99(67.3)
11-20 81(38.0) 33(50.0) 48(32.7) > 20 3(1.4) 3(4.5) 0
Fall history in one year 57(26.8) 20(30.3) 37(25.5) 0.468
Disturbing pain 65(30.5) 34(51.5) 31(21.4) < 0.001 Depression 31(14.6) 25(37.9) 6(4.1) < 0.001 Self-reported memory impairment 119(56.4) 43(65.2) 76(52.4) 0.084 characteristics(continuous)
Age(Years) 71.1(3.9) 71.3(4.0) 71.0(3.9) 0.603
Body mass index (kg/m2) 25.3(3.5) 24.6(3.8) 25.7(3.3) 0.034 Number of comorbidity 3.4(2.0) 3.8(2.2) 3.1(1.9) 0.045 MMSE 25.1(3.7) 24.4(4.1) 25.4(3.5) 0.113
Barthel Index score 98.5(4.2) 98.0(5.7) 98.8(3.3) 0.735
Vitamin D insufficiency = 25-hydroxyvitamin D < 20 ng/mL; Depression including mild, moderate, moderately severe
depression by PHQ9 (Patient Health Questionnaire 9 assessment); MMSE: Mini-mental State Examination. P indicates t-test for continuous variables, and the χ
2 or Fisher exact test for categorical variables.
Vitamin D insufficiency Prevalence rate :31%
Vit DCommunity
33
Frailty Level with the Frequency of Recent 1 year Admission, Emergency Visit and Fall Analysis
Item預後項目
Robust (N=39)
Pre-frail(N=87)
Frail(N=27)
Linearity p
Adjusted p
Post-hoc
Ad time 0.10 ± 0.31 0.21 ± 0.46 0.56 ± 1.05 .002 .006 1<3
ER time 0.10 ± 0.31 0.29 ± 0.68 0.81 ± 1.39 .000 .001 1<3
Ad+ER time 1.14 ± 0.38 1.72 ± 1.06 3.70 ± 2.36 .001 .001 1<3
Fall time 0.41 ± 0.68 0.89 ± 1.86 1.22 ± 1.95 .053 .134
Frailty outcome
34
Comparison of Geriatric Assessment between Baseline and 1year Follow-up Analysis
Baseline After 1yr follow-up
Item Frail group Mean (SD) Mean (SD) t p
自評功能 (WONCA)
Robust 14.13 (1.66) 13.90 (1.45) 1.120 0.270
Pre-frail 15.36 (2.72) 15.60 (2.88) -0.850 0.398
Frail 18.11 (3.76) 19.52 (4.94) -1.455 0.158
簡式症狀 (BSRS-5)
Robust 3.56 (2.90) 2.82 (2.25) 2.069 0.045
Pre-frail 3.46 (3.51) 2.93 (3.38) 1.500 0.137
Frail 4.96 (4.42) 5.15 (5.39) -0.288 0.776
簡式智能評估 (MMSE)Robust 28.05 (2.41) 27.72 (2.51) 1.242 0.222
Pre-frail 26.09 (3.86) 25.63 (4.31) 2.031 0.045
Frail 21.30 (5.88) 21.00 (6.03) 0.365 0.718
老年憂鬱症狀 (GDS)
Robust 2.21 (2.14) 2.18 (2.21) 0.091 0.928
Pre-frail 3.38 (3.53) 3.23 (3.46) 0.517 0.606
Frail 7.93 (4.60) 7.00 (4.38) 1.335 0.194
迷你營養評估 (MNA)
Robust 26.78 (1.89) 26.51 (1.91) 1.452 0.155
Pre-frail 26.18 (1.80) 25.65 (2.25) 2.653 0.010
Frail 22.72 (2.38) 22.46 (2.98) 0.373 0.712
巴氏 (Barthel)
Robust 99.87 (0.80) 99.74 (1.12) 1.000 0.324
Pre-frail 97.87 (5.37) 97.36 (5.75) 1.085 0.281
Frail 89.07 (17.76) 82.78(26.25) 2.185 0.038
工具日常生活功能(IADL)
Robust 6.69 (1.56) 6.28 (1.50) 2.343 0.024
Pre-frail 5.66 (1.81) 5.39 (1.85) 1.983 0.051
Frail 4.41 (2.04) 3.78 (2.36) 2.148 0.041
Frailty outcome
35
Frailty level with the score changes of quality of life (QOL) between baseline and after 1 year follow-up analysis
Baseline After 1yr follow-up
Item Frailty group Mean (SD) Mean (SD) t p
Robust 14.54 (2.02) 13.90 (1.57) 2.709 0.010
Physiological domain Pre-frail 14.13 (2.27) 13.84 (2.28) 1.348 0.181
身體 Frail 12.70 (1.94) 12.41 (2.47) 0.625 0.537
Robust 13.44 (2.10) 13.26 (2.04) 0.685 0.497
Psychological domain Pre-frail 13.02 (2.35) 12.55 (2.54) 1.990 0.050
心理 Frail 10.63 (2.91) 11.04 (3.67) -0.635 0.531
Robust 13.87 (2.41) 12.92 (1.61) 3.088 0.004
Social domain Pre-frail 13.23 (2.55) 12.82 (2.16) 1.667 0.099
社會 Frail 12.22 (3.33) 11.52 (2.75) 0.945 0.354
Robust 13.95 (2.37) 13.26 (1.57) 2.610 0.013
Social domain (Taiwan) Pre-frail 13.62 (2.15) 13.11 (1.77) 2.380 0.020
Frail 12.74 (3.56) 11.93 (2.50) 1.354 0.187
Robust 14.56 (1.65) 14.08 (1.44) 2.155 0.038
Environmental domain Pre-frail 15.01 (1.93) 14.61 (2.37) 1.624 0.108
環境 Frail 14.70 (1.98) 14.22 (2.39) 1.235 0.228
Environmental domain Robust 14.82 (1.54) 14.28 (1.40) 2.448 0.019
(Taiwan) Pre-frail 15.07 (1.87) 14.63 (2.25) 1.858 0.067
Frail 14.85 (1.96) 14.15 (2.40) 1.927 0.065
生活品質
Frailty outcome
First Stage Telephone Screen (N=2900)
Second Stage Hospital Screen
Eligible, N=548
Category 3 n = 236
Category 4 n = 224
Category 5 n = 69
Category 6 n = 19
Excluded, N=2352
Not-eligible (Category 1 n=206、Category 2 n=86、Category 7 n=5)
Refusal n=998, communication barrier n=43,
can’t reach after 3 attempts n=1004,
death n=6, institutionalized n=4
Randomization, N=159
Refuse, N=274
Refusal, N=38
Baseline assessment, N=121 (Enrolled)
Intervention Assessments, N=117
CHS_PCF evaluation, N=274
Robust n=80
Pre-frail n=161
Frail n=31
Missing n=2Excluded, N=115
Robust n=62
Other exclusion criteria n=52
Refusal, N=4
收案流程圖 社區老年人整合型照護計畫Community Intervention
受試者在介入前之比較受試者在介入前之比較社區老年人整合型照護計畫
Community Intervention
受試者在介入後衰弱症評估結果受試者在介入後衰弱症評估結果社區老年人整合型照護計畫
Community Intervention
39
2020健康白皮書老年族群健康指標
衰弱及失能之防治跌倒及骨折之防治憂鬱症及自殺之防治復健及中風後失能之防治預立指示之簽署與執行
知識轉譯知識轉譯
40
目標與因應策略彙整表
2020健康國民白皮書:高齡化族群
目標 積極老化/預防失能指標 老人衰弱及失能之防治因應策略
1. 規劃老人衰弱防治策略,透過立法,整合各部會資源。
2. 研訂老人衰弱篩檢表,推廣自我篩檢、老人健檢、社區篩檢。
3. 結合縣市政府或社群團體,發展社區篩檢及社區運動,並透過社區志工、學生社團或學生服務,關懷社區老人。
4. 強化基層家庭醫師之老人照護。
5. 強化老年專科醫師之周全性老年評估
6. 加強老人及家屬/照顧者之衰弱察覺與照護。
7. 落實社區健康中心老人照護團隊服務。
8. 建立各層級老人照護制度、相關品管與財務規劃。
9. 加強老人衰弱相關研究,找出衰弱危險因數及有效介入。
知識轉譯
AcknowledgementAcknowledgement
Research team members Case managers 陳慶餘醫師 Chen, CY
陳晶瑩醫師 Chen,Crystal CY
嚴崇仁醫師 Yan, CR
劉文俊醫師 Liu, WC
郭旭格醫師 Kuo, HK
陳人豪醫師 Chen, JH
詹鼎正醫師 Chan, DC
張皓翔醫師 Cheng, HS
蔡兆勳醫師 Tsai, JS
吳治勳博士Wu, CH
呂貝蕾 Bei-Lei Lu
林妤嬪 Yu-Ping Lin
林美月Mei-Yeh Lin
張淑玲 Shu-Ling Chang
41
Thank you for your attentionThank you for your attention
42